Drug Combination Details
General Information of the Combination (ID: C49723) | |||||
---|---|---|---|---|---|
Name | Eugenol NP Info | + | 2-methoxyestradiol Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Prostate cancer
[ICD-11: 2C82]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Molecule(s)
Regulation |
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | LNCaP | CVCL_0395 | Prostate carcinoma | Homo sapiens | ||
PC-3 | CVCL_0035 | Prostate carcinoma | Homo sapiens | |||
DU145 | CVCL_0105 | Prostate carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Combining 2-ME(2) with eugenol (i) inhibited growth of prostate cancer cells and induced apoptosis at lower concentrations than either single agent alone. |

